REGENXBIO Inc
BioTech/Drugs - Rockville, MD, US
REGENXBIO Inc Senior Management
REGENXBIO Inc Details
REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno‐associated virus (AAV) gene therapy. REGENXBIO's NAV® Technology Platform, a proprietary AAV gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10. REGENXBIO's mission is to transform the lives of patients suffering from severe diseases with significant unmet medical need by developing and commercializing in vivo gene therapy products based on REGENXBIO's NAV Technology Platform. REGENXBIO seeks to accomplish this mission through a combination of internal development efforts and third‐party NAV Technology Platform licensees.
REGENXBIO Inc Technologies
Email Providers
Outlook
CMS
Drupal
Other
Microsoft Office 365
Hosting
Microsoft Azure Hosting
Search Marketing
Adobe Marketing Cloud
CSS and JavaScript Libraries
Bootstrap Framework v3.2.0